Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
about
Utilizing electronic health records to predict acute kidney injury risk and outcomes: workgroup statements from the 15(th) ADQI Consensus ConferenceLipids, blood pressure and kidney update 2015Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Optimal timing of renal replacement therapy initiation in acute kidney injury: the elephant felt by the blindmen?Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk AssessmentPredicting acute kidney injury: current status and future challenges.Sepsis: frontiers in supportive care, organisation and research.Biomarkers in acute kidney injury - pathophysiological basis and clinical performance.Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury.Acute kidney injury in the fetus and neonate.Early-phase cumulative hypotension duration and severe-stage progression in oliguric acute kidney injury with and without sepsis: an observational study.Volume-related weight gain as an independent indication for renal replacement therapy in the intensive care units.Moderator's view: Patient-centered approaches for optimizing AKI management: the role of kidney biomarkers.Hospital-acquired acute kidney injury: an analysis of baseline estimated glomerular filtration rate and in-hospital mortality.Systematic review of prognostic prediction models for acute kidney injury (AKI) in general hospital populations.The Furosemide Stress Test and Predicting AKI OutcomesThe Golden Hours of AKI: Is Oxygen Delivery the Key?Renal Stress Testing in the Assessment of Kidney Disease.Personalized physiological medicine.Optimal Role of the Nephrologist in the Intensive Care Unit.Prevention and Therapy of Acute Kidney Injury in the Developing World.Does this patient with AKI need RRT?Understanding oliguria in the critically ill.Have renal biomarkers failed in acute kidney injury? Yes.Con: Cautionary tales and reservations about the adoption of new technologies and biomarkers for the management of acute kidney injury.Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels.[New kidney function tests: Renal functional reserve and furosemide stress test].Phenotyping of Acute Kidney Injury: Beyond Serum Creatinine.Tubular Transport in Acute Kidney Injury: Relevance for Diagnosis, Prognosis and Intervention.Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial).Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials.Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.Focus on acute kidney injury and fluidsTiming of Renal Replacement Therapy in Acute Kidney Injury: Shedding New Light on an Old Controversy
P2860
Q26765778-D760E12F-9059-4F28-B99D-D29102B0383BQ26771550-EB34ADA7-7007-4009-BFB4-519223FDE02FQ30234560-D22F30AE-767D-4B5E-8D73-F600BE195643Q33814491-AAB715D2-6942-4FE8-8AAD-870BC171D333Q37038600-FEC83949-E9B6-492B-92A2-8D7A2804EAC8Q38669818-28E22C9B-75B0-4DBF-A6E9-5A3710C53415Q38764864-9CB5755B-CD48-4C0B-9513-9B021358CDF9Q38836197-C5FBA31D-458E-4B8A-8E28-D6A79EAB29D9Q39003626-6E42C3A3-745C-4FDD-8D85-A8597D2B89E2Q39062499-12C3CFA9-3AB3-42B9-9030-2A89C335CD07Q39088188-55C9C8B7-B04D-4BBB-92AA-4EAD024C93F2Q39294708-F5BA301B-005A-4034-A149-246CBF693341Q40259182-3893A9FA-0D46-48EB-B096-9CA7B7683C3CQ41189183-BEC355BF-81B1-4893-BC30-0ACD5F002BF8Q41855668-E32B8032-4748-4BEB-959F-84A82F8A6514Q42407774-C26F04CD-E9A7-47EE-974A-381C43C2D5D0Q42423010-6EFD0A72-D88A-4C45-959B-EDCFDD13D270Q45011167-4E2BA41B-E9BB-4211-8052-B1F89BDAC4BFQ47148355-2F5FCDE3-F778-4170-8FBA-7BA120C237DDQ47171707-D48EE8D2-9ED1-4AFD-A41E-F0B747C50F7FQ47361874-2AE09FED-9784-4443-B015-E993A3123D0FQ47613094-60A55BBA-AFE5-4C52-A49B-FF731D0545A0Q48358848-4FC6E956-500D-4BD1-94A6-45CCB598BAF4Q49100662-5E550D66-A4B0-4A20-ACA1-24161E4C3278Q49106320-5C699E46-E753-4EDB-98A7-2383DC3FCDBDQ49565460-294CB280-1104-4C21-AB51-6E715E89E059Q50073624-8C3B869D-B377-4E36-B206-3CD0238DBDB0Q52733199-ACA071DF-B72B-43C0-94ED-36E78B551447Q54982342-957E7448-C778-4BBB-8BC2-7056EA5A2F0DQ55028217-BBC47EDF-361D-4272-BBB2-B1C984F87DF7Q55095941-F59DF4D8-F5F9-4B32-98B3-1C9AFFBA796EQ55385257-121C0E73-2B37-4B5A-9664-C0D3F1144D1AQ56967907-CD8E319A-C095-4B90-B4CC-CC79DB65D2AAQ58593070-DD421DDE-9E12-4F75-B2D4-5BD85FAA7F76
P2860
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
@ast
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
@en
type
label
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
@ast
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
@en
prefLabel
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
@ast
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
@en
P2093
P2860
P50
P356
P1476
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.
@en
P2093
Danielle L Davison
Divya M Chalikonda
Ermira Brasha-Mitchell
James A Tumlin
Jay L Koyner
Michael G Seneff
Michael R Bennett
Paul L Kimmel
Sharon A Trevino
P2860
P304
P356
10.1681/ASN.2014060535
P577
2015-02-05T00:00:00Z